Neurizon inks $1.5M loan against R&D Tax Rebate
Neurizon Therapeutics (ASX:NUZ) retreated in intra-day trade on Wednesday after inking a non-dilutive loan agreement for $1.5 million to fund its current and future operations seeking to treat Huntington’s with its flagship drug NUZ-001.The funds in question are secured against it...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
PYM | Ann: Update - Consolidation/Split - PYM-PYM.AX | 02/06/16 | 14 | 11K | |||
|
|||||||
PYM | Ann: Update - Consolidation/Split - PYM-PYM.AX | 24/05/16 | 0 | 1.5K | |||
|
|||||||
PYM | Ann: Results of Meeting-PYM.AX | 18/05/16 | 0 | 1.2K | |||
|
|||||||
PYM | Ann: Chairman's Address to Shareholders-PYM.AX | 18/05/16 | 0 | 1.6K | |||
|
|||||||
PYM | Ann: March 2016 Quarterly Activity Report & Appendix 5B-PYM.AX | 17/05/16 | 2 | 1.9K | |||
|
|||||||
PYM | Ann: New Website Address-PYM.AX | 22/04/16 | 0 | 860 | |||
|
|||||||
PYM | Ann: Consolidation/Split - PYM-PYM.AX | 14/04/16 | 0 | 931 | |||
|
|||||||
PYM | Ann: Notice of Annual General Meeting/Proxy Form-PYM.AX | 11/04/16 | 0 | 676 | |||
|
See All Discussions